[PDF][PDF] Clinical epidemiology of cardiovascular disease in chronic renal disease

RN Foley, PS Parfrey, MJ Sarnak - American Journal of Kidney …, 1998 - academia.edu
● The risk of cardiovascular disease (CVD) in patients with chronic renal disease (CRD)
appears to be far greater than in the general population. For example, among patients treated …

Epidemiology of cardiovascular disease in chronic renal disease.

RN Foley, PS Parfrey, MJ Sarnak - Journal of the American Society …, 1998 - europepmc.org
The risk of cardiovascular disease in patients with chronic renal disease appears to be far
greater than in the general population. For example, among patients treated by hemodialysis …

US renal data system 2011 annual data report

AJ Collins, RN Foley, B Chavers, D Gilbertson… - American journal of …, 2012 - ajkd.org
Foley, MB … Foley … Suggested Citation: Collins AJ, Foley RN, Chavers B, et al: US
Renal Data System 2011 Annual Data Report. Am J Kidney Dis. 2012;59(1)(suppl 1):e1-e420. …

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

RN Foley, PS Parfrey, JD Harnett, GM Kent, CJ Martin… - Kidney international, 1995 - Elsevier
Foley is the 1992 Baxter/Canadian Society of Nephrology/Kidney Foundation of Canada
Research Fellow. Christopher Martin held a Summer Studentship from Memorial Univer- …

Excerpts from the US renal data system 2009 annual data report

AJ Collins, RN Foley, C Herzog, BM Chavers… - American journal of …, 2010 - ajkd.org
Foley, MB … Foley … Suggested Citation: Collins AJ, Foley RN, Herzog C, et al. Excerpts
from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis. …

Outcome and risk factors for left ventricular disorders in chronic uraemia

PS Parfrey, RN Foley, JD Harnett… - Nephrology Dialysis …, 1996 - academic.oup.com
Background Left ventricular disease occurs frequently in dialysis patients. It may be manifest
as concentric LV hypertrophy, LV dilatation with or without LV hypertrophy, or systolic …

[PDF][PDF] Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?

…, BE Coronado, G Eknoyan, RN Foley… - American Journal of …, 1998 - academia.edu
CVD is the leading cause of death in ESRD. CVD often begins well before the onset of the
end-stage of CRD and is associated with recognizable risk factors. In the general population, …

Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999

RN Foley, AM Murray, S Li, CA Herzog… - Journal of the …, 2005 - journals.lww.com
Abstract Knowledge of the excess risk posed by specific cardiovascular syndromes could
help in the development of strategies to reduce premature mortality among patients with …

The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease

RN Foley, PS Parfrey, JD Harnett, GM Kent… - American journal of …, 1996 - Elsevier
… The patients in this study are the same as those reported by Foley and colleagues,‘5-17 …
Dr Foley was the 1992-1994 Baxter/Canadian … FOLEY ET AL …

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors

JD Harnett, RN Foley, GM Kent, PE Barre, D Murray… - Kidney international, 1995 - Elsevier
Foley was a Baxter/Canadian Society of Nephrology/Kidney Foundation of Canada Fellow.
FOLEY RN, PARFREY PS, HARNETr JD, KENT KM, MARTIN CJ, MURRAY DC, BA.iRE PE: …